Wright Medical Group N.V. Announces Preliminary Fourth Quarter and Full-Year 2018 Net Sales
Fourth Quarter 2018 Net Sales, Including Cartiva, of Approximately $238 Million Full-Year 2018 Net Sales, Including Cartiva, of Approximately $836 […]
OPKO Health Appoints Jon R. Cohen, M.D. Executive Chairman of BioReference Laboratories
Geoff Monk promoted to President MIAMI, Jan. 07, 2019 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) today announced the […]
Phase 3 Trial of Mesoblast’s Cell Therapy in Chronic Heart Failure Completes Recruitment
NEW YORK and MELBOURNE, Australia, Jan. 07, 2019 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), world leader in development and […]
Radware to Acquire ShieldSquare for Expansion of Its Cloud Security Portfolio
ShieldSquare’s Cloud-Based Anti-Bot Solutions Help Online Businesses Differentiate Between Human & Non-Human Traffic on Websites, Mobile Applications & APIs MAHWAH, […]
Wright Medical Group N.V. Announces Organizational Changes to Further Drive Long-Term Growth and Profitability
Organizational Changes Designed to Sustain Double-Digit Growth Rates, Advance Global Commercial Focus and Further Transform Business Processes Company to Present […]
Fintech Select Increases Focus in Online and Mobile Payments
TORONTO, Jan. 07, 2019 (GLOBE NEWSWIRE) — Fintech Select Ltd. (“Fintech Select” or the “Company”) (TSX-V: FTEC) is pleased to […]
MediPharm Labs Commences Trading in United States on OTCQB Market Under Symbol MLCPF
TORONTO, Jan. 07, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV:LABS) (OTCQB:MLCPF) (the “Company” or “MediPharm Labs”), a specialized, research-driven […]
Kraken Completes Majority Acquisition of Kraken Power GmbH
Kraken Power Achieves ISO 9001:2015 Certification ST. JOHN’S, Newfoundland, Jan. 07, 2019 (GLOBE NEWSWIRE) — Kraken Robotics Inc. (TSX-V: PNG) […]
Nuvectra® Announces Preliminary Unaudited Fourth Quarter and Full Year 2018 Revenue
PLANO, Texas, Jan. 07, 2019 (GLOBE NEWSWIRE) — Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today preliminary […]
Vital Therapies and Immunic Therapeutics Announce Transaction to Create Leading Inflammatory and Autoimmune Disease Company
– Transaction Expected to Create NASDAQ-listed Biopharmaceutical Company Focused on Advancing Immunic‘s Compelling Pipeline of Clinical-Stage and Late Preclinical Assets […]
